Christina R. Chow
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Protein Degradation and Inhibitors, Protein Kinase Regulation and GTPase Signaling, Multiple Myeloma Research and Treatments, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → G Protein Subunit Gα 13 Binds to Integrin α IIb β 3 and Mediates Integrin “Outside-In” Signaling(2010)252 cited
- → BET Bromodomain Inhibitors Block Growth of Pancreatic Cancer Cells in Three-Dimensional Collagen(2014)96 cited
- → GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1(2015)90 cited
- → Signalling mechanisms of RhoGTPase regulation by the heterotrimeric G proteins G12 and G13(2011)77 cited
- → Effect of lipophilicity on drug distribution and elimination: Influence of obesity(2021)76 cited
- → The Chromatin Remodeling Gene ARID1A Is a New Prognostic Marker in Clear Cell Renal Cell Carcinoma(2013)71 cited
- → Differential Regulation of ZEB1 and EMT by MAPK-Interacting Protein Kinases (MNK) and eIF4E in Pancreatic Cancer(2015)66 cited
- → Impaired Rivaroxaban Clearance in Mild Renal Insufficiency With Verapamil Coadministration: Potential Implications for Bleeding Risk and Dose Selection(2017)46 cited
- → HLA associations with infliximab-induced liver injury(2020)33 cited
- → Minimal Physiologically Based Pharmacokinetic and Drug‐Drug‐Disease Interaction Model of Rivaroxaban and Verapamil in Healthy and Renally Impaired Subjects(2017)28 cited